DIA 2017
June 18-22, 2017
Chicago, IL
Menu Back to Committee
DIA 2017

DIA 2017 is located at:

McCormick Place
Gate 4
2301 South Martin Luther King Jr. Drive
Chicago, IL
Go

Program Committee

  • Teresa Ancukiewicz, MA
    Teresa Ancukiewicz, MA • Senior Manager, Clinical Data Management
    Boston Scientific Corporation, United States
  • Kimberly Belsky, MS
    Kimberly Belsky, MS • Senior Director, Regulatory Affairs, Regulatory Policy and Intelligence
    Mallinckrodt Pharmaceuticals, United States
  • Larry A. Blankstein, PhD
    Larry A. Blankstein, PhD • Head of Clinical Operations
    Synlogic, United States
  • Daniel M. Bollag, PhD
    Daniel M. Bollag, PhD • Senior Vice President, Pharmacovigilance and Quality
    Ocular Therapeutics, United States
  • Linda Bowen, MSc, RAC
    Linda Bowen, MSc, RAC • Assistant Professor
    Temple University, United States
  • Bill Byrom, PhD
    Bill Byrom, PhD • Vice President, Product Strategy and Innovation
    CRF Health , United Kingdom
  • Joy A. Cavagnaro
    Joy A. Cavagnaro • President
    Access BIO, United States
  • Dannis Chang, PharmD
    Dannis Chang, PharmD • Senior Director, Global Medical Information and Scientific Communications
    Halozyme Therapeutics Inc., United States
  • Karla Childers, MS
    Karla Childers, MS • Senior Director, Strategic Projects, Office of the Chief Medical Officer
    Johnson & Johnson, United States
  • Leah Christl, PhD
    Leah Christl, PhD • Associate Director for Therapeutic Biologics, TBBS, OND, CDER
    FDA, United States
  • Brenda Crowe, PhD
    Brenda Crowe, PhD • Senior Research Advisor, Global Statistical Sciences
    Eli Lilly and Company, United States
  • Sara Doshi, PharmD
    Sara Doshi, PharmD • Director, Medical Information Strategy and Capabilities, GMI
    Eli Lilly and Company, United States
  • Betsy Fallen, RN
    Betsy Fallen, RN • Consultant
    BAFallen Consulting LLC, United States
  • Barbara Gladson, PhD, MS
    Barbara Gladson, PhD, MS • Director of Biopharma Initiative; Interim Chair, Health Informatics
    Rutgers School of Health Professions, United States
  • Richard Gliklich, MD
    Richard Gliklich, MD • Chief Executive Officer
    OM1, United States
  • Jonathan Haddad, MPH
    Jonathan Haddad, MPH • Director, Clinical Statistics
    GlaxoSmithKline, United States
  • Martin Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM • Principal International Affairs Officer
    European Medicines Agency, European Union, United Kingdom
  • Jonathan Solomon Helfgott, MS
    Jonathan Solomon Helfgott, MS • Executive Director, Global Regulatory/Clinical Affairs
    Stage 2 Innovations, United States
  • Frank Hubbard, PhD
    Frank Hubbard, PhD • President
    Global Regulatory Writing Solutions, Inc., United States
  • Virginia Hussong
    Virginia Hussong • Chief, Data Standards Program, CBER
    FDA, United States
  • Nita Ichhpurani, PMP
    Nita Ichhpurani, PMP •
    Canada
  • John Kamp
    John Kamp • Executive Director
    Coalition For Healthcare Communication, United States
  • Sean Y. Kassim, PhD
    Sean Y. Kassim, PhD • Director, Office of Study Integrity and Surveillance, OTS, CDER
    FDA, United States
  • Ellen Kelso
    Ellen Kelso • Head, Knowledge Strategy
    KSE Ltd., United States
  • Lisa Kim, MS
    Lisa Kim, MS • Director of Capstone / Lecturer
    Rutgers School of Health Professions, United States
  • Lynn King, MHA
    Lynn King, MHA • Executive Director, Clinical Management
    PPD , United States
  • Agnes V. Klein, MD
    Agnes V. Klein, MD • Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
    Health Canada, Canada
  • Stephen Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP • Vice President, Drug Safety and Pharmacovigilance
    Halozyme Therapeutics, United States
  • Mark A. Kryah, PMP
    Mark A. Kryah, PMP • Senior Advisor/COO, Bio-Medicines Business Unit
    Eli Lilly and Company, United States
  • Andrea C. Masciale, JD
    Andrea C. Masciale, JD • Vice President, Regulatory Policy and Global Analytics
    Johnson & Johnson, United States
  • Ann Meeker-O'Connell, MS
    Ann Meeker-O'Connell, MS • Senior Director/ Head, BioResearch Quality and Compliance, Consumer Products
    Johnson & Johnson, United States
  • Mary Stober Murray, MBA
    Mary Stober Murray, MBA • Associate Director, Diversity and Patient Engagement
    Bristol-Myers Squibb, United States
  • Bob Muzerall
    Bob Muzerall • Vice President, Sales & Sales Training
    AMPLEXOR Life Sciences, LLC, United States
  • Jane E. Myles, MS
    Jane E. Myles, MS • Head, Operational Intelligence and Innovation
    Genentech, A Member of the Roche Group, United States
  • Roger Nosal, PhD
    Roger Nosal, PhD • Vice President, Global CMC
    Pfizer Inc, United States
  • Christine Pierre, RN
    Christine Pierre, RN • President
    Society for Clinical Research Sites, United States
  • Sarah Pope Miksinski, PhD
    Sarah Pope Miksinski, PhD • Senior Director, Global Regulatory Affairs
    AstraZeneca, United States
  • Kim Quaintance-Lunn
    Kim Quaintance-Lunn • Vice President, Regulatory Policy, NA
    Bayer, United States
  • Badri Rengarajan, MD
    Badri Rengarajan, MD • Medical Affairs Lead, ASPIRE Unit
    Actelion, United States
  • Margaret Richards, PhD, MPH
    Margaret Richards, PhD, MPH • Executive Director, Scientific Affairs, Real-World Solutions
    PRA Health Sciences, United States
  • Mitra Rocca, MSc
    Mitra Rocca, MSc • Associate Director, Medical Informatics, Office of Translational Science, CDER
    FDA, United States
  • Matthew D. Rotelli, PhD
    Matthew D. Rotelli, PhD • Director, Global PK/PD and Pharmacometrics
    Eli Lilly and Company, United States
  • Leslie Sam
    Leslie Sam • Experienced Quality Professional
    Consultant, United States
  • David H. Schubert
    David H. Schubert • Vice President of Regulatory and Quality
    Stealth BioTherapeutics, United States
  • Leigh Shultz, PhD
    Leigh Shultz, PhD • Associate Vice President, Project Management
    Merck & Co., Inc., United States
  • Ashley F. Slagle, PhD, MS
    Ashley F. Slagle, PhD, MS • Principal, Scientific and Regulatory Consulting
    Aspen Consulting, LLC, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS • Assistant Professor, Clinical Pharmacy; Educational Liaison & Instructor, ICRS
    University of Southern California, United States
  • William B. Smith, MD
    William B. Smith, MD • President
    VRG/NOCCR, An AMR Company, United States
  • Elizabeth Somers, MSc, PMP
    Elizabeth Somers, MSc, PMP • Executive Director of Infectious Disease, Global Project and Alliance Management
    Merck & Co., Inc., United States
  • Jeffrey N. Stuart, PhD, RAC
    Jeffrey N. Stuart, PhD, RAC • Global Regulatory Director, Oncology, Immunology, and InVitro Diagnostics
    Merck & Co., Inc., United States
  • Ling Su, DIAFellow, PhD
    Ling Su, DIAFellow, PhD • Past President, DIA Board of Directors; Professor
    Shenyang Pharmaceutical University, China
  • Toshiyoshi Tominaga, PhD
    Toshiyoshi Tominaga, PhD • Associate Executive Director (for International Programs)
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh • Vice President, Lifecycle Safety
    IQVIA, United States
Load More